Simple, Practical Ways to Assess the Protective Efficacy of a New Tuberculosis Vaccine
Open Access
- 1 June 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (Supplement) , S250-S253
- https://doi.org/10.1086/313870
Abstract
There is strong evidence that tuberculin sensitivity cannot be used to evaluate the efficacy of different strains of bacille Calmette-Guérin (BCG). FKeywords
This publication has 9 references indexed in Scilit:
- Field trials of tuberculosis vaccines: How could we have done them better?Controlled Clinical Trials, 1994
- Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCGInfection and Immunity, 1993
- Identification of an Effective Vaccine Against TuberculosisAmerican Review of Respiratory Disease, 1988
- BCG Identification by DNA Restriction Fragment PatternsMicrobiology, 1987
- Augmentation of immunity to line 10 hepatoma by BCG. Comparison of different BCG preparationsCancer, 1980
- Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigsJournal of Biological Standardization, 1979
- Virulence of Six Strains of Mycobacterium bovis (BCG) in MiceInfection and Immunity, 1973